Bharat Biotech's nasal Covid-19 booster gets nod for trial in India
The Drugs Controller General of India (DCGI) has given its approval to Bharat Biotech for trials of its intranasal Covid booster dose in India.
Other Pharmaceuticals Videos
AI in Pharma: How India's Drug Giants Are Betting Big on Artificial Intelligence
The brutal leadership lesson that shaped Dr. Reddy’s chief
We are discovery rich, but development poor
Budget 2026: India’s pharma leap, BioPharma SHAKTI gets ₹10K cr; 1,000 clinical trial sites planned
Corner Office Conversation: Nandini Piramal of Piramal Pharma & Arjun Juneja of Mankind Pharma
